Table 3.
Endothelial Cell Type | Evidence of ICRAC Involvement | Function | Reference |
---|---|---|---|
Ea.hy926 | Orai1DN | ER Ca2+ refilling | [154] |
HUVECs | siSTIM1 and siOrai1, OraiDN, Synta66, BTP-2, GSK | Proliferation, cell cycle control (S and G2/M phase), tube formation | [38,39,143] |
HUVECs | siSTIM1, STIM1over, BTP-2 | Migration | [60] |
Rat aortic endothelial cells | 10–100 µM GSK (IC50 = 34.22 µM) | Aorta sprouting | [143] |
Mouse retinal vasculature | 2.6–31.8 mg/kg GSK (IC50 = 18.4 mg/kg) | Neovessel formation | [143] |
Porcine aortic endothelial cells | siSTIM1 | NO release | [160] |
Endothelial cells from mesenteric resistance and thoracic arteries | STIM1EC-/- mice | NO release and vasorelaxation | [161,162] |
Mouse cerebrovascular endothelial cells | 20 µM BTP-2, 10 µM La3+ | NO release | [175] |
Human cerebrovascular endothelial cells | 10 µM Pyr6 | NO release | [62,169] |
Abbreviations: Orai1DN: expression of dominant negative Orai1; siOrai1: small interfering RNA selectively targeting Orai1; siSTIM1: small interfering RNA selectively targeting STIM1; STIM1EC-/- mice: endothelial cell-specific knockout mice; STIM1over: STIM1 overexpression.